Other languages Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
13.68 ^CNY	+1.94%		+5.23%	-11.11%

Jul. 02	Tranche Update on Apeloa Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 27, 2024.	CI
Jun. 04	Tranche Update on Apeloa Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 27, 2024.	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17
Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023	Apr. 09
Apeloa Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 300 million worth of its shares.	Mar. 27
Apeloa Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	Mar. 26
Apeloa Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2023	Mar. 08
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Apeloa Pharmaceutical to Co-Develop Antibody Drug Conjugates With Zhenge Biotechnology	Mar. 06
Apeloa Pharmaceutical to Scrap Sofadil for Injection Clinical Trial for Stroke	Jan. 29
Apeloa Pharmaceutical's Profit Climbs 13.6% in Q3	23-10-19
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18
Apeloa Pharmaceutical to Cooperate With Wuhan Hopson Technology on Customized Production Projects	23-10-18
Apeloa Pharma Unit Passes US FDA On-Site Inspection	23-09-22
Apeloa Pharmaceutical's Unit Passes US FDA's Inspection	23-09-13
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14
Apeloa Pharma Forms Strategic Drug Alliance With Zelgen Biopharma	23-06-13
Apeloa Pharmaceutical to Sell 95% Stake in Injection Unit for 38 Million Yuan	23-05-18
Apeloa Pharmaceutical Co.,Ltd Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 22 May 2023	23-05-16
Apeloa Pharmaceutical Co.,Ltd Approves Election of Pan Weiguang as Independent Director	23-04-19
Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022	23-04-19
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

Other languages

Filters